Stem cell transplant ‘cures’ diabetic miceInsulin-producing cells from human embryos have treated animals with type 1 diabetesdoi:10.1016/S0262-4079(08)60321-8Andy CoghlanThe New Scientist
K. et al. Cellular senescence in type 2 diabetes: a therapeutic opportunity. Diabetes 64, 2289–2298 (2015). CAS PubMed PubMed Central Google Scholar Thompson, P. J. et al. Targeted elimination of senescent beta cells prevents type 1 diabetes. Cell Metab. 29, 1045–1060 (2019). CAS ...
by researchers at the University of California, Davis, is the first to demonstrate how a bioengineered scaffold made up of human mesenchymal stem cells (MSCs) combined with timolol — a drug commonly used to treat glaucoma
Mesenchymal stem cells alleviate rat diabetic nephropathy by suppressing CD103+ DCs-mediated CD8+ T cell responses. J. Cell. Mol. Med. 2020, 24, 5817–5831. [Google Scholar] [CrossRef] [Green Version] Wang, R.; Chen, T.; Wang, C.; Zhang, Z.; Wang, X.M.; Li, Q.; Lee, V....
As new therapies for diabetic retinopathy are available (from laser-based therapies to vitrectomy and intravitreal corticosteroids, antivascular endothelial growth factors, and more advanced stem cells and ribonucleic acid interference technologies), it becomes demanding to evaluate all the risk factors of...